Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PathScale is a high-performance computing (HPC) company that provides optimizing compilers and low-latency networking solutions essential for data-intensive life science research. Founded in 2001, the company became renowned for its EKOPath compiler suite and InfiniPath (later TrueScale) technology, which provided the computational backbone for genomics, molecular docking, and protein folding simulations. By optimizing code for complex biological algorithms, PathScale's tools have been instrumental in accelerating high-throughput virtual screening and large-scale genomic assembly projects. Although the company's core assets have transitioned through acquisitions by QLogic and Intel, the PathScale brand continues to offer high-performance software and infrastructure for AI, bioinformatics, and complex engineering. Its technology remains a staple in academic and industrial laboratories that require massive computational scale to solve intricate structural biology and drug discovery challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PathScale.